Systemic Treatments Outcomes for Moderate-to-Severe Atopic Dermatitis in Children Aged Less Than 12 Years: PEDISTAD 5-Year Results

Amy S. Paller, Northwestern University The Feinberg School of Medicine, Wilmette, IL, United States; Alan D. Irvine, School of Medicine, Trinity College Dublin, Dublin, Dublin, Ireland; Lawrence F.. Eichenfield, University of California, San Diego and Rady Children’s Hospital, San Diego, San Diego, CA, United States; Lin Ma, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, beijing, Beijing, China (People's Republic); Lara Wine Lee, Medical University of South Carolina, Charleston, SC, United States; Joel C. Joyce, Endeavor Health, Chicago, IL, United States; Marlies de Graaf, UMC Utrecht, Utrecht, Utrecht, Netherlands; Mercedes E. E. Gonzalez, Pediatric Skin Research, LLC, Miami, FL, United States; Rajan Gupta, TechData Service Company, Houston, TX, United States; Adriana Mello, Sanofi, Cambridge, MA, United States; Marius Ardeleanu, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States; Annie Zhang, Sanofi, Cambridge, MA, United States